Opioid Induced Constipation Drugs Market Report

Europe Opioid Induced Constipation Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Apr 23, 2020
  • PAGES：153
  • REPORT CODE：GMM530701
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Opioid Induced Constipation Drugs market was valued at 0.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Opioid Induced Constipation Drugs Market Segmentations:

    By Player:

    • Cosmo Pharmaceuticals SA

    • Pfizer

    • Takeda Pharmaceutical Company Limited

    • Progenics Pharmaceuticals Inc

    • Daiichi Sankyo Co Ltd

    • Allergan Plc

    • Sucampo Pharmaceuticals

    • Purdue Pharma

    • Daewoong Pharmaceutical

    • Theravance Biopharma Inc

    • Nektar Therapeutics

    • Mundipharma International Limited

    • Valeant Pharmaceuticals International

    • Ironwood Pharmaceuticals Inc

    By Type:

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Others

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Induced Constipation Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • 1.3.2 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2014 to 2026

    • 1.3.3 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine from 2014 to 2026

    • 1.3.4 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan from 2014 to 2026

    • 1.3.5 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.3 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioid Induced Constipation Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid Induced Constipation Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Lubiprostone

      • 3.4.2 Market Size and Growth Rate of Methyl Naltrexone Bromide

      • 3.4.3 Market Size and Growth Rate of Naldemedine

      • 3.4.4 Market Size and Growth Rate of Alvimopan

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Opioid Induced Constipation Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid Induced Constipation Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hospital Pharmacies for Construction

      • 4.4.2 Market Size and Growth Rate of Retail Pharmacies for Construction

      • 4.4.3 Market Size and Growth Rate of Online Pharmacies for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Opioid Induced Constipation Drugs Production Analysis by Top Regions

    • 5.2 Europe Opioid Induced Constipation Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Opioid Induced Constipation Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Opioid Induced Constipation Drugs Landscape Analysis

    • 7.1 Germany Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 7.2 Germany Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    8. UK Opioid Induced Constipation Drugs Landscape Analysis

    • 8.1 UK Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 8.2 UK Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    9. France Opioid Induced Constipation Drugs Landscape Analysis

    • 9.1 France Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 9.2 France Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    10. Italy Opioid Induced Constipation Drugs Landscape Analysis

    • 10.1 Italy Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 10.2 Italy Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    11. Spain Opioid Induced Constipation Drugs Landscape Analysis

    • 11.1 Spain Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 11.2 Spain Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    12. Poland Opioid Induced Constipation Drugs Landscape Analysis

    • 12.1 Poland Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 12.2 Poland Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    13. Russia Opioid Induced Constipation Drugs Landscape Analysis

    • 13.1 Russia Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 13.2 Russia Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    14. Switzerland Opioid Induced Constipation Drugs Landscape Analysis

    • 14.1 Switzerland Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    15. Turkey Opioid Induced Constipation Drugs Landscape Analysis

    • 15.1 Turkey Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Opioid Induced Constipation Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Opioid Induced Constipation Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Opioid Induced Constipation Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Cosmo Pharmaceuticals SA

      • 19.1.1 Cosmo Pharmaceuticals SA Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Pfizer

      • 19.2.1 Pfizer Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Takeda Pharmaceutical Company Limited

      • 19.3.1 Takeda Pharmaceutical Company Limited Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Progenics Pharmaceuticals Inc

      • 19.4.1 Progenics Pharmaceuticals Inc Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Daiichi Sankyo Co Ltd

      • 19.5.1 Daiichi Sankyo Co Ltd Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Allergan Plc

      • 19.6.1 Allergan Plc Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Sucampo Pharmaceuticals

      • 19.7.1 Sucampo Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Purdue Pharma

      • 19.8.1 Purdue Pharma Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Daewoong Pharmaceutical

      • 19.9.1 Daewoong Pharmaceutical Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Theravance Biopharma Inc

      • 19.10.1 Theravance Biopharma Inc Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Nektar Therapeutics

      • 19.11.1 Nektar Therapeutics Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Mundipharma International Limited

      • 19.12.1 Mundipharma International Limited Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Valeant Pharmaceuticals International

      • 19.13.1 Valeant Pharmaceuticals International Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Ironwood Pharmaceuticals Inc

      • 19.14.1 Ironwood Pharmaceuticals Inc Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    The List of Tables and Figures (Totals 82 Figures and 163 Tables)

    • Figure Product Picture

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Germany Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioid Induced Constipation Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioid Induced Constipation Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid Induced Constipation Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different Types from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan Market, 2015 - 2026 (USD Million)

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioid Induced Constipation Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different End-Users from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Production by Major Regions

    • Table Europe Opioid Induced Constipation Drugs Production Share by Major Regions

    • Figure Europe Opioid Induced Constipation Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Opioid Induced Constipation Drugs Consumption by Major Regions

    • Table Europe Opioid Induced Constipation Drugs Consumption Share by Major Regions

    • Table Germany Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table UK Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table France Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Germany Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table UK Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table France Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table France Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table France Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Italy Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Spain Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Poland Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Russia Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Cosmo Pharmaceuticals SA Profiles

    • Table Cosmo Pharmaceuticals SA Production, Value, Price, Gross Margin 2014-2019

    • Table Cosmo Pharmaceuticals SA Product benchmarking

    • Table Cosmo Pharmaceuticals SA Strategic initiatives

    • Table Cosmo Pharmaceuticals SA SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Takeda Pharmaceutical Company Limited Profiles

    • Table Takeda Pharmaceutical Company Limited Production, Value, Price, Gross Margin 2014-2019

    • Table Takeda Pharmaceutical Company Limited Product benchmarking

    • Table Takeda Pharmaceutical Company Limited Strategic initiatives

    • Table Takeda Pharmaceutical Company Limited SWOT analysis

    • Table Progenics Pharmaceuticals Inc Profiles

    • Table Progenics Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Progenics Pharmaceuticals Inc Product benchmarking

    • Table Progenics Pharmaceuticals Inc Strategic initiatives

    • Table Progenics Pharmaceuticals Inc SWOT analysis

    • Table Daiichi Sankyo Co Ltd Profiles

    • Table Daiichi Sankyo Co Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Daiichi Sankyo Co Ltd Product benchmarking

    • Table Daiichi Sankyo Co Ltd Strategic initiatives

    • Table Daiichi Sankyo Co Ltd SWOT analysis

    • Table Allergan Plc Profiles

    • Table Allergan Plc Production, Value, Price, Gross Margin 2014-2019

    • Table Allergan Plc Product benchmarking

    • Table Allergan Plc Strategic initiatives

    • Table Allergan Plc SWOT analysis

    • Table Sucampo Pharmaceuticals Profiles

    • Table Sucampo Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Sucampo Pharmaceuticals Product benchmarking

    • Table Sucampo Pharmaceuticals Strategic initiatives

    • Table Sucampo Pharmaceuticals SWOT analysis

    • Table Purdue Pharma Profiles

    • Table Purdue Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Purdue Pharma Product benchmarking

    • Table Purdue Pharma Strategic initiatives

    • Table Purdue Pharma SWOT analysis

    • Table Daewoong Pharmaceutical Profiles

    • Table Daewoong Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Daewoong Pharmaceutical Product benchmarking

    • Table Daewoong Pharmaceutical Strategic initiatives

    • Table Daewoong Pharmaceutical SWOT analysis

    • Table Theravance Biopharma Inc Profiles

    • Table Theravance Biopharma Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Theravance Biopharma Inc Product benchmarking

    • Table Theravance Biopharma Inc Strategic initiatives

    • Table Theravance Biopharma Inc SWOT analysis

    • Table Nektar Therapeutics Profiles

    • Table Nektar Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Nektar Therapeutics Product benchmarking

    • Table Nektar Therapeutics Strategic initiatives

    • Table Nektar Therapeutics SWOT analysis

    • Table Mundipharma International Limited Profiles

    • Table Mundipharma International Limited Production, Value, Price, Gross Margin 2014-2019

    • Table Mundipharma International Limited Product benchmarking

    • Table Mundipharma International Limited Strategic initiatives

    • Table Mundipharma International Limited SWOT analysis

    • Table Valeant Pharmaceuticals International Profiles

    • Table Valeant Pharmaceuticals International Production, Value, Price, Gross Margin 2014-2019

    • Table Valeant Pharmaceuticals International Product benchmarking

    • Table Valeant Pharmaceuticals International Strategic initiatives

    • Table Valeant Pharmaceuticals International SWOT analysis

    • Table Ironwood Pharmaceuticals Inc Profiles

    • Table Ironwood Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Ironwood Pharmaceuticals Inc Product benchmarking

    • Table Ironwood Pharmaceuticals Inc Strategic initiatives

    • Table Ironwood Pharmaceuticals Inc SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US